Birinyi Associates’s CVS Health CVS Stock Holding History

Birinyi Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,500	Closed	-$409K	–	73
2019 Q4	$409K	Hold	5,500	–	–	0.17%	62
2019 Q3	$347K	Hold	5,500	–	–	0.15%	66
2019 Q2	$300K	Hold	5,500	–	–	0.13%	68
2019 Q1	$297K	Hold	5,500	–	–	0.13%	65
2018 Q4	$360K	Hold	5,500	–	–	0.18%	55
2018 Q3	$433K	Hold	5,500	–	–	0.15%	67
2018 Q2	$354K	Hold	5,500	–	–	0.14%	76
2018 Q1	$342K	Hold	5,500	–	–	0.14%	77
2017 Q4	$399K	Hold	5,500	–	–	0.18%	70
2017 Q3	$447K	Hold	5,500	–	–	0.21%	61
2017 Q2	$443K	Hold	5,500	–	–	0.21%	66
2017 Q1	$432K	Hold	5,500	–	–	0.21%	68
2016 Q4	$434K	Hold	5,500	–	–	0.25%	63
2016 Q3	$489K	Hold	5,500	–	–	0.26%	59
2016 Q2	$527K	Hold	5,500	–	–	0.23%	61
2016 Q1	$571K	Sell	5,500 -1,000	-15%	-$97.2K	0.25%	57
2015 Q4	$636K	Sell	6,500 -2,066	-24%	-$202K	0.41%	55
2015 Q3	$826K	Buy	8,566 +4,541	+113%	+$477K	0.36%	56
2015 Q2	$422K	Sell	4,025 -1,000	-20%	-$102K	0.29%	62
2015 Q1	$519K	Buy	5,025 +2,000	+66%	+$202K	0.34%	55
2014 Q4	$291K	Hold	3,025	–	–	0.13%	79
2014 Q3	$241K	Sell	3,025 -2,500	-45%	-$197K	0.11%	84
2014 Q2	$416K	Buy	5,525 +2,500	+83%	+$189K	0.19%	65
2014 Q1	$226K	Hold	3,025	–	–	0.11%	75
2013 Q4	$216K	Hold	3,025	–	–	0.12%	74
2013 Q3	$172K	Buy	+3,025	New	+$180K	0.1%	77

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Birinyi Associates's CVS Position: Q1 2020 in Review

Birinyi Associates sold out of CVS Health (CVS) in Q1 2020, closing a stake of 5,500 shares — an estimated $409K sold.

Birinyi Associates first reported a position in CVS in Q3 2013 and held it in 26 quarters. The position peaked at $826K in Q3 2015. 1,817 funds tracked by Wall St. Rank hold CVS as of Q1 2020.

Birinyi Associates reported no remaining CVS Health position as of Q1 2020 after selling out during the quarter.
Birinyi Associates sold 5,500 CVS Health shares in Q1 2020, an estimated $409K.
Birinyi Associates first reported a position in CVS Health in Q3 2013 and held it in 26 quarters.
Birinyi Associates's CVS Health position peaked at $826K in Q3 2015.
1,817 funds tracked by Wall St. Rank held CVS Health as of Q1 2020.

Based on Birinyi Associates's 13F filing for Q1 2020, filed 12 May 2020.